WKN: | 851311 |
ISIN: | CH0012032113 |
Land: | Schweiz |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Roche-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 18. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1993 | 30,87 | 66,99 | 116,99% |
2 | 1997 | 86,11 | 137,65 | 59,86% |
3 | 1995 | 67,26 | 102,60 | 52,54% |
4 | 1992 | 20,77 | 30,87 | 48,63% |
5 | 2005 | 97,05 | 141,00 | 45,28% |
6 | 2021 | 286,63 | 394,54 | 37,65% |
7 | 2019 | 212,45 | 282,98 | 33,20% |
8 | 2002 | 91,99 | 120,61 | 31,11% |
9 | 2013 | 154,87 | 201,87 | 30,35% |
10 | 2011 | 114,20 | 137,25 | 20,18% |
11 | 1991 | 17,61 | 20,77 | 17,97% |
12 | 2015 | 222,69 | 254,50 | 14,29% |
13 | 2012 | 137,25 | 154,87 | 12,84% |
14 | 2014 | 201,87 | 222,69 | 10,31% |
15 | 2006 | 141,00 | 153,76 | 9,05% |
16 | 1998 | 137,65 | 150,10 | 9,05% |
17 | 2009 | 114,02 | 122,04 | 7,04% |
18 | 1999 | 150,10 | 157,69 | 5,06% |
19 | 2024 | 281,15 | 288,36 | 2,57% |
20 | 2020 | 282,98 | 286,63 | 1,29% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2001 | 132,11 | 91,99 | -30,37% |
2 | 2023 | 362,97 | 281,15 | -22,54% |
3 | 2007 | 153,76 | 128,69 | -16,31% |
4 | 2000 | 157,69 | 132,11 | -16,22% |
5 | 1996 | 102,60 | 86,11 | -16,08% |
6 | 2016 | 254,50 | 222,02 | -12,76% |
7 | 2004 | 109,94 | 97,05 | -11,72% |
8 | 2008 | 128,69 | 114,02 | -11,40% |
9 | 2003 | 120,61 | 109,94 | -8,85% |
10 | 2022 | 394,54 | 362,97 | -8,00% |
11 | 2010 | 122,04 | 114,20 | -6,42% |
12 | 2017 | 222,02 | 210,41 | -5,23% |
13 | 2025 | 288,36 | 282,20 | -2,14% |
14 | 1994 | 66,99 | 67,26 | 0,41% |
15 | 2018 | 210,41 | 212,45 | 0,97% |
16 | 2020 | 282,98 | 286,63 | 1,29% |
17 | 2024 | 281,15 | 288,36 | 2,57% |
18 | 1999 | 150,10 | 157,69 | 5,06% |
19 | 2009 | 114,02 | 122,04 | 7,04% |
20 | 1998 | 137,65 | 150,10 | 9,05% |